Recombinant Human IL-11 Attenuates the Inflammatory Response Through Down-Regulation of Proinflammatory Cytokine Release and Nitric Oxide Production

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3627-3634

  Trepicchio, William L ^a   Bozza, Mary ^a   Pedneault, Glen ^a   Dorner, Andrew J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; SECRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030587817     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Turner, K. J., and S. C. Clark. 1995. Interleukin-11: biological and clinical perspectives. In Hematopoietic Growth Factors in Clinical Applications. R. Mertelsmann, and F. Herrmann, eds. Marcel Dekker, New York, pp. 315-335.
2. Goldman, S. J. 1995. Preclinical biology of interleukin-elevin: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 13:462.
3. Nebin, S., and K. Turner. 1993. The biology of Interleukin-11. Stem Cells 11:156.
4. Tepler, I., L. Elias, J. W. Smith, M. Hussein, G. Rosen, A. Y.-C. Chang, J. Moore, M. S. Gordon, B. Kuca, K. J. Beach, J. W. Loewy, M. B. Garnick, and J. A. Kaye. 1996. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607.
5. Keith, J. C., Jr., L. Albert, S. T. Sonis, C. J. Pfeiffer, and R. G. Schaub. 1994. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 1:79.
6. Sonis, S., A. Muska, J. O'Brien, A. van Vugt, P. Langer-Safer, and J. Keith. 1995. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur. J. Cancer B Oral Oncol. 31:261.
7. Du, X. X., C. M. Doerschuk, A. Orazi, and D. A. Williams. 1994. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33.
8. Arend, W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:151.
9. Feldmann, M., F. M. Brennan, M. Elliott, P. Katsikis, and R. N. Maini. 1994. TNF alpha as a therapeutic target in rheumatoid arthritis. Circ. Shock 43:179.
10. Henson, P. M., and D. W. Riches. 1994. Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation. Ann. NY Acad. Sci. 725:298.
11. Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53:288.
12. Woessner, J., Jr. 1994. The family of matrix metalloproteinases. Ann. NY Acad. Sci. 732:11.
13. Krane, S. M. 1994. Clinical importance of metalloproteinases and their inhibitors. Ann. NY Acad. Sci. 732:1.
14. Dileepan, K. N., J. C. Page, Y. Li, and D. J. Stechschulte. 1995. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma. J. Interferon Cytokine Res. 15:387.
15. Sartor, R. B. 1994. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533.
16. Florentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
17. Bogdan, C., Y. Vodovotz, and C. F. Nathan. 1992. Regulation of macrophage functions by macrophage deactivating factor, a tumor cell derived cytokine. In Mononuclear Phagocytes: Activation, Role and Cytokinetics. R. van Furth, ed. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 381-388.
18. Nathan, C., and Q.-w. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915.
19. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
20. Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319.
21. Barton, B. E., and J. V. Jackson. 1993. Protective role of Interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61:1496.
22. Poli, V., F. P. Mancini, and R. Cortese. 1990. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63:643.
23. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
24. Aderka, D., J. M. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517.
25. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.1
26. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
27. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
28. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. J. Immunol.155:4347.
29. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243.
30. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177:511.
31. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029.
32. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J.Immunol. 141:2407.
33. Breese, E. J., C. A. Michie, S. W. Nicholls, S. H. Murch, C. B. Williams, P. Domizio, J. A. Walker-Smith, and T. T. MacDonald. 1994. Tumor necrosis factor alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455.
34. MacDonald, T. T., P. Hutchings, M.-Y. Choy, S. Murch, and A. Cooke. 1990. Tumor necrosis factor alpha and interferon gamma production measured at the single cell level in normal and inflamed human intestine. Clin. Exp. Immunol. 81:301.
35. Plevy, S. E., S. R. Targan, T. Andus, and H. Toyoda. 1993. TNF-α mRNA levels differentiate mucosal inflammation in Crohn's disease from ulcerative colitis. J. Immunol. 150:10.
36. Murch, S. H., V. A. Lamkin, M. O. Savage, J. A. Walker-Smith, and T. T. MacDonald. 1991. Serum levels of tumor necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 32:913.
37. Mahida, Y. R., K. Wu, and D. P. Jewell. 1989. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30:835.
38. Ligumsky, M., P. L. Simon, F. Karmeli, and D. Rachmilewitz. 1990. Role of IL-1 in inflammatory bowel disease. Enhanced production during active disease. Gut 31:686.
39. Abreu-Martin, M. T., A. Vidrich, D. H. Lynch, and S. R. Targan. 1995. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen. J. Immunol. 155:4147.
40. Rodriguez, P., M. Heyman, C. Candalh, M. A. Blaton, and C. Bouchoud. 1995. Tumor necrosis factor α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 7:441.
41. McCartney-Francis, N., J. Allen, D. Mizel, J. Albina, Q.-w. Xie, C. Nathan, and S. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749.
42. Derkx, B., J. Taminiau, S. Radema, A. Stronkhorst, C. Wortel, G. Tytgat, and S. van Deventer. 1993. Tumor necrosis factor antibody treatment in Crohn's disease. Lancet 342:173.
43. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of IL-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute phase response. Clin. Exp. Rheumatol. 19:348.
44. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collage-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
45. Stout, R. D. 1993. Macrophage activation by T cells: cognate and non-cognate signals. Curr. Opin. Immunol. 5:398.
46. Wolf, S. F., D. Sieburth, and J. Sypek. 1994. Interleukin 12: a key modulator of immune function. Stem Cells 12:154.
47. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141.
48. Kopp, E. B., and S. Ghosh. 1995. NF-kappa B and rel proteins in innate immunity. Adv. Immunol. 58:1.
49. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558.
50. van Dullemen, H. M., S. J. van Deventer, D. W. Hommes, H. A. Bijl, J. Jansen, G. N. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody. Gastroenterology 109:129.
51. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Bijl, and J. N. Woody. 1994. Repeated therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125.